Delnova Unveils Partnership With Pace Life Sciences To Boost Capabilities

DelNova has announced a strategic partnership with Pace® Life Sciences to serve as their contract development and manufacturing organization (CDMO). This collaboration is aimed at advancing DelNova's candidate Rescue Drug, ReViVox®, designed to address unwanted side effects that may occur after Botulinum Neurotoxin (BoNT) therapy, including well-known US brands like BOTOX®, DYSPORT®, XEOMIN®, and JEUVEAU®.

Pace® Life Sciences brings essential expertise to support DelNova in completing investigational new drug (IND)-enabling research for future FDA submissions. This includes work on formulation, kinetics, and stability. DelNova is actively seeking funding opportunities, both dilutive and non-dilutive, including an application submitted to the Small Business Innovation Research (SBIR) program.

Furthermore, through this partnership with Pace® Life Sciences, DelNova gains the capability to manufacture small Good Manufacturing Practice (GMP) batches of drug products for clinical studies. Pace® Life Sciences, with its specialized CDMO facility in San Diego, excels in complex drug delivery, formulation, and sterile fill-finish GMP manufacturing.

Mary Gardner, CEO and Founder of DelNova, and Frank Tagliaferri, PhD, Vice President of Pharmaceutical Development at Pace® Life Sciences, are enthusiastic about this collaboration. They bring extensive pharmaceutical development expertise to DelNova's efforts. Currently, there is no available product to reverse unwanted paralysis induced by BoNTs, making ReViVox® potentially the first of its kind to address this medical need.

Pace® Life Sciences is a comprehensive provider of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services for the pharmaceutical, biopharmaceutical, and gene therapy industries. DelNova's ReViVox® is poised to address complications arising from off-target muscle paralysis following aesthetic and medical neurotoxin therapies, filling a crucial void in the industry.

This partnership underscores the commitment of both companies to advance medical solutions and improve patient outcomes in the field of neurotoxin therapy.

More Information : https://www.techdogs.com/tech-news/pr-newswire/delnova-unveils-partnership-with-pace-life-sciences-to-boost-capabilities

Comments

Post a Comment

Popular posts from this blog

Cloud Computing Trends 2025

Image
  When you gaze at the clouds drifting in the sky, what do you perceive? A world of endless possibilities, right? Their shapes are ever-changing, evolving gracefully as they stretch across the horizon. They are in a constant state of flux, with new formations appearing at every moment. No matter how they transform, they always contribute to the larger tapestry of the sky, giving it depth and meaning. This dynamic nature is what makes clouds so captivating, serving as a reminder that our surroundings are also in a state of change—bringing with it new opportunities. The same holds true for cloud computing, which is perpetually evolving and influencing technology. Nowadays, it’s not merely about storing data; it’s about how businesses harness the flow of information, adapting and expanding to meet new challenges and demands. As we look ahead to 2025, just as clouds shift and adapt, cloud computing is reshaping our lives and work, opening up new avenues for businesses, technologists, a...
Read more

Everything About Conscious AI: Can AI Become Self Aware?

Image
  Imagine watching I, Robot with its curious, self-questioning robot Sonny—a machine programmed to follow orders yet pondering its existence. What if such a scenario wasn’t confined to sci-fi? As Artificial Intelligence (AI) integrates into daily life, some researchers believe AI could someday develop a degree of consciousness. A recent survey suggests that about 24% of AI experts think machines might achieve self-awareness in the coming decades. But what does "AI consciousness" mean? Essentially, it would involve AI having self-awareness, reflecting on actions, and making subjective decisions. The journey toward conscious AI has milestones, including the development of neural networks, backpropagation, and breakthroughs in deep learning. Today’s systems, like ChatGPT or DALL-E, can mimic human-like tasks but lack true self-awareness. The question is whether machines can bridge this gap between advanced data processing and genuine consciousness. Experts are divided; optimi...
Read more

Sales Technology Trends That Will Impact Your Business In 2025

Image
  The way we sell has transformed dramatically, from cold-calling and door-to-door pitches to digital platforms that connect businesses with the right audiences. The iconic movie The Internship humorously depicted this shift—Billy and Nick, seasoned salesmen, struggled with Google’s tech-driven approach but eventually learned that technology enhances, not replaces, talent. As we enter 2025, businesses must adopt emerging sales technologies to stay competitive. Here are five key trends that will redefine sales in the coming year. 1. Relationship-Driven Sales Consumers today expect more than just a product pitch; they seek meaningful relationships with brands. By 2025, AI-driven personalization will dominate sales strategies. With 96% of customers researching before engaging with sales reps, businesses must prioritize tailored interactions. CRM tools integrated with AI and sentiment analysis will allow sales teams to predict customer needs, personalize outreach, and engage more e...
Read more